AbbVie Inc (ABBV)
176.93
+5.20
(+3.03%)
USD |
NYSE |
Nov 22, 16:00
177.07
+0.14
(+0.08%)
After-Hours: 20:00
AbbVie Cash from Operations (Quarterly): 5.447B for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.447B |
| June 30, 2024 | 2.271B |
| March 31, 2024 | 4.04B |
| December 31, 2023 | 4.753B |
| September 30, 2023 | 7.574B |
| June 30, 2023 | 6.319B |
| March 31, 2023 | 4.193B |
| December 31, 2022 | 7.428B |
| September 30, 2022 | 7.602B |
| June 30, 2022 | 5.005B |
| March 31, 2022 | 4.908B |
| December 31, 2021 | 5.075B |
| September 30, 2021 | 7.935B |
| June 30, 2021 | 4.89B |
| March 31, 2021 | 4.877B |
| December 31, 2020 | 4.854B |
| September 30, 2020 | 5.83B |
| June 30, 2020 | 3.089B |
| March 31, 2020 | 3.815B |
| December 31, 2019 | 3.275B |
| September 30, 2019 | 4.555B |
| June 30, 2019 | 2.477B |
| March 31, 2019 | 3.017B |
| December 31, 2018 | 3.392B |
| September 30, 2018 | 4.524B |
| Date | Value |
|---|---|
| June 30, 2018 | 2.866B |
| March 31, 2018 | 2.645B |
| December 31, 2017 | 2.584B |
| September 30, 2017 | 3.271B |
| June 30, 2017 | 2.003B |
| March 31, 2017 | 2.102B |
| December 31, 2016 | 1.541B |
| September 30, 2016 | 1.454B |
| June 30, 2016 | 1.918B |
| March 31, 2016 | 2.128B |
| December 31, 2015 | 1.963B |
| September 30, 2015 | 2.155B |
| June 30, 2015 | 1.832B |
| March 31, 2015 | 1.585B |
| December 31, 2014 | -578.00M |
| September 30, 2014 | 1.786B |
| June 30, 2014 | 1.717B |
| March 31, 2014 | 624.00M |
| December 31, 2013 | 1.245B |
| September 30, 2013 | 1.798B |
| June 30, 2013 | 2.037B |
| March 31, 2013 | 1.187B |
| December 31, 2012 | 941.00M |
| September 30, 2012 | 2.249B |
| June 30, 2012 | 1.561B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
2.271B
Minimum
Jun 2024
7.935B
Maximum
Sep 2021
5.159B
Average
4.899B
Median
Cash from Operations (Quarterly) Benchmarks
| Amgen Inc | 3.571B |
| Johnson & Johnson | 7.993B |
| Eli Lilly and Co | 3.712B |
| Merck & Co Inc | 9.291B |
| Pfizer Inc | 6.714B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -8.256B |
| Cash from Financing (Quarterly) | -3.072B |
| Free Cash Flow | 15.62B |
| Free Cash Flow Per Share (Quarterly) | 2.933 |
| Free Cash Flow to Equity (Quarterly) | 4.753B |
| Free Cash Flow to Firm (Quarterly) | 5.642B |
| Free Cash Flow Yield | 4.98% |